Cargando…
Usage of L-type calcium channel blockers to suppress drug reward and memory driving addiction: Past, present, and future
Over the past three decades, L-type Ca(2+) channel (LTCC) blockers have been considered a potential therapeutic drug to alleviate the symptoms of drug addiction. This idea has been supported, in part, by 1) expression of LTCCs in the brain dopaminergic circuits that are thought to play critical role...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476140/ https://www.ncbi.nlm.nih.gov/pubmed/36241085 http://dx.doi.org/10.1016/j.neuropharm.2022.109290 |